BioCardia, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2024 | 1 | -$1.19 | -$1.19 | -$1.19 |
| Q3 2024 | 1 | -$0.87 | -$0.87 | -$0.87 |
BioCardia, Inc. Earnings Date And Information
BioCardia, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.88 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1 by $0.78. The company had revenue of 0 for the quarter and had revenue of 477,000 for the year. BioCardia, Inc. has generated $-8 earnings per share over the last year ($-8.19 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. BioCardia, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based on prior year's report dates.
BioCardia, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$61.43 | $200,000 | $0 | ||
| 08/13/2024 | Q2 2024 | -$0.10 | -$0.88 | -0.78 | $50,000 | $3,000 |
| 05/14/2024 | Q1 2024 | -$1.35 | $55,000 | |||
| 03/27/2024 | Q4 2023 | -$1.65 | -$1.38 | 0.27 | $13,000 | |
| 11/08/2023 | Q3 2023 | -$0.12 | -$1.79 | -1.67 | $50,000 | $357,000 |
| 08/09/2023 | Q2 2023 | -$0.15 | -$2.52 | -2.37 | $183,500 | $43,000 |
| 05/10/2023 | Q1 2023 | -$0.13 | -$2.60 | -2.47 | $64,000 | |
| 05/01/2023 | Q4 2022 | -$2.49 | $106,000 | |||
| 11/09/2022 | Q3 2022 | -$0.23 | -$2.57 | -2.34 | $113,000 | $212,000 |
| 08/10/2022 | Q2 2022 | -$0.28 | -$2.12 | -1.84 | $92,000 | $974,000 |
| 05/11/2022 | Q1 2022 | -$0.15 | -$2.92 | -2.77 | $60,000 | |
| 03/29/2022 | Q4 2021 | -$0.21 | -$3.05 | -2.84 | $79,000 | |
| 11/10/2021 | Q3 2021 | -$0.21 | -$2.38 | -2.17 | $30,000 | $821,000 |
| 08/12/2021 | Q2 2021 | -$0.21 | -$3.07 | -2.86 | $33,500 | $69,000 |
| 05/13/2021 | Q1 2021 | -$0.21 | -$2.69 | -2.48 | $46,000 | |
| 03/30/2021 | Q4 2020 | -$0.31 | -$3.37 | -3.06 | $46,000 | |
| 11/10/2020 | Q3 2020 | -$0.28 | -$4.57 | -4.29 | $83,000 | $34,000 |
| 08/13/2020 | Q2 2020 | -$0.25 | -$6.95 | -6.7 | $179,000 | $27,000 |
| 05/15/2020 | Q1 2020 | -$10.09 | $38,000 | |||
| 04/09/2020 | Q4 2019 | -$0.41 | -$7.69 | -7.28 | $215,000 |
BioCardia, Inc. Earnings: Frequently Asked Questions
-
When is BioCardia, Inc.'s earnings date?
BioCardia, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates.
-
How can I listen to BioCardia, Inc.'s earnings conference call?
The conference call for BioCardia, Inc.'s latest earnings report can be listened to online.
-
How can I read BioCardia, Inc.'s conference call transcript?
The conference call transcript for BioCardia, Inc.'s latest earnings report can be read online.
-
How much revenue does BioCardia, Inc. generate each year?
BioCardia, Inc. (:BCDA) has a recorded annual revenue of $477,000.
-
How much profit does BioCardia, Inc. generate each year?
BioCardia, Inc. (:BCDA) has a recorded net income of $477,000. BioCardia, Inc. has generated $-8.19 earnings per share over the last four quarters.
-
What is BioCardia, Inc.'s price-to-earnings ratio?
BioCardia, Inc. (:BCDA) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is -0.
